Schachat AP - Search Results

1

Successful photodynamic therapy with verteporfin for recurrent choroidal neovascularization beneath the new fovea after macular translocation surgery with 360-degree retinotomy.

Sawa M, Chan WM, Ohji M, Imai K, Fujikado T, Tano Y, Schachat AP. Sawa M, et al. Among authors: schachat ap. Am J Ophthalmol. 2003 Sep;136(3):560-3. doi: 10.1016/s0002-9394(03)00268-x. Am J Ophthalmol. 2003. PMID: 12967821

2

Macular translocation: unifying concepts, terminology, and classification.

Au Eong KG, Pieramici DJ, Fujii GY, Ng EW, Humayun MS, Maia M, Harlan JB Jr, Schachat AP, Beatty S, Toth CA, Thomas MA, Lewis H, Eckardt C, Tano Y, de Juan E. Au Eong KG, et al. Among authors: schachat ap. Am J Ophthalmol. 2001 Feb;131(2):244-53. doi: 10.1016/s0002-9394(00)00788-1. Am J Ophthalmol. 2001. PMID: 11228303 Review.

3

Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.

Blinder KJ, Blumenkranz MS, Bressler NM, Bressler SB, Donato G, Lewis H, Lim JI, Menchini U, Miller JW, Mones JM, Potter MJ, Pournaras C, Reaves A, Rosenfeld P, Schachat AP, Schmidt-Erfurth U, Sickenberg M, Singerman LJ, Slakter JS, Strong HA, Virgili G, Williams GA. Blinder KJ, et al. Among authors: schachat ap. Ophthalmology. 2003 Apr;110(4):667-73. doi: 10.1016/s0161-6420(02)01998-x. Ophthalmology. 2003. PMID: 12689884 Clinical Trial.

4

Inferior limited macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: 1-year visual outcome and recurrence report.

Fujii GY, de Juan E Jr, Pieramici DJ, Humayun MS, Phillips S, Reynolds SM, Melia M, Schachat AP. Fujii GY, et al. Among authors: schachat ap. Am J Ophthalmol. 2002 Jul;134(1):69-74. doi: 10.1016/s0002-9394(02)01511-8. Am J Ophthalmol. 2002. PMID: 12095810

5

Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.

Pieramici DJ, De Juan E Jr, Fujii GY, Reynolds SM, Melia M, Humayun MS, Schachat AP, Hartranft CD. Pieramici DJ, et al. Among authors: schachat ap. Am J Ophthalmol. 2000 Oct;130(4):419-28. doi: 10.1016/s0002-9394(00)00533-x. Am J Ophthalmol. 2000. PMID: 11024414 Clinical Trial.

6

Complications associated with limited macular translocation.

Fujii GY, Pieramici DJ, Humayun MS, Schachat AP, Reynolds SM, Melia M, De Juan E Jr. Fujii GY, et al. Among authors: schachat ap. Am J Ophthalmol. 2000 Dec;130(6):751-62. doi: 10.1016/s0002-9394(00)00771-6. Am J Ophthalmol. 2000. PMID: 11124294 Free article.

7

Initial experience of inferior limited macular translocation for subfoveal choroidal neovascularization resulting from causes other than age-related macular degeneration.

Fujii GY, Humayun MS, Pieramici DJ, Schachat AP, Au Eong KG, de Juan E Jr. Fujii GY, et al. Among authors: schachat ap. Am J Ophthalmol. 2001 Jan;131(1):90-100. doi: 10.1016/s0002-9394(00)00769-8. Am J Ophthalmol. 2001. PMID: 11162983 Clinical Trial.

8

Retrospective case series of juxtafoveal choroidal neovascularization treated with photodynamic therapy with verteporfin.

Blair MP, Apte RS, Miskala PH, Bressler SB, Goldberg MF, Schachat AP, Bressler NM. Blair MP, et al. Among authors: schachat ap. Retina. 2004 Aug;24(4):501-6. doi: 10.1097/00006982-200408000-00001. Retina. 2004. PMID: 15300069

9

Angiographic features and outcome of questionable recurrent choroidal neovascularization.

Dyer DS, Brant AM, Schachat AP, Bressler SB, Bressler NM. Dyer DS, et al. Among authors: schachat ap. Am J Ophthalmol. 1995 Oct;120(4):497-505. doi: 10.1016/s0002-9394(14)72664-9. Am J Ophthalmol. 1995. PMID: 7573308

10

Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2.

Barbazetto I, Burdan A, Bressler NM, Bressler SB, Haynes L, Kapetanios AD, Lukas J, Olsen K, Potter M, Reaves A, Rosenfeld P, Schachat AP, Strong HA, Wenkstern A; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group; Verteporfin in Photodynamic Therapy Study Group. Barbazetto I, et al. Among authors: schachat ap. Arch Ophthalmol. 2003 Sep;121(9):1253-68. doi: 10.1001/archopht.121.9.1253. Arch Ophthalmol. 2003. PMID: 12963608

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters